WEKO3
アイテム
{"_buckets": {"deposit": "402853de-e100-4f34-9ad3-ddfae4c34dcc"}, "_deposit": {"id": "22763", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "22763"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00022763", "sets": ["456", "1205"]}, "item_7_alternative_title_1": {"attribute_name": "その他のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "Anti-Acetylcholine Receptor Antibody and Myasthenia Gravis(Receptor Diseases)"}]}, "item_7_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1989-10", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "10", "bibliographicPageEnd": "800", "bibliographicPageStart": "798", "bibliographicVolumeNumber": "103", "bibliographic_titles": [{"bibliographic_title": "新潟医学会雑誌"}, {"bibliographic_title": "新潟医学会雑誌", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Anti-acetylcholine receptor (AChR) antibody is highly disease-specific to myasthenia gravis (MG) comparing to other autoimmune disease, and it is rare to detect other autoimmune antibody. Therefore, immune tolerance system of MG seems to be somewhat different from other autoimmune diseases. However, there is a variation in anti-AChR antibody and anti-AChR antibody is not always correlate with clinical severity. AChR is composed of five subunits, two of α and each one of β, γ and δ and has transmembrane stracture. Fifty percent of antibody to native AChR bind to and more than a half of antibody of patient with MG bind to one region, which is called main immunogenic region (MIR) and is located on α subunit. Peptide mapping of each subunit has high homology. Localization of MIR is not established yet. Farther study of MIR, study of AChR using monoclonal antibody to peptid and establishment of antigenic region on AChR are needed.", "subitem_description_type": "Abstract"}]}, "item_7_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "137918", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Nagai, Hiroko"}]}]}, "item_7_publisher_7": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "新潟医学会"}]}, "item_7_select_19": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "永井, 博子"}], "nameIdentifiers": [{"nameIdentifier": "137917", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-19"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "103(10)_798-800.pdf", "filesize": [{"value": "1.1 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 1100000.0, "url": {"label": "103(10)_798-800.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/22763/files/103(10)_798-800.pdf"}, "version_id": "a87a4e03-0199-4d33-91e4-bf6fa0afc46d"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Myasthenia gravis", "subitem_subject_scheme": "Other"}, {"subitem_subject": "anti-acetylcholine receptor antibody", "subitem_subject_scheme": "Other"}, {"subitem_subject": "acetylcholine receptor", "subitem_subject_scheme": "Other"}, {"subitem_subject": "peptide map", "subitem_subject_scheme": "Other"}, {"subitem_subject": "重症筋無力症", "subitem_subject_scheme": "Other"}, {"subitem_subject": "抗アセチルコリンレセプター抗体", "subitem_subject_scheme": "Other"}, {"subitem_subject": "アセチルコリンレセプター", "subitem_subject_scheme": "Other"}, {"subitem_subject": "ペプチドマップ", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "2) アセチルコリンレセプター抗体と重症筋無力症(シンポジウム レセプターとその臨床, 第443回新潟医学会)", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "2) アセチルコリンレセプター抗体と重症筋無力症(シンポジウム レセプターとその臨床, 第443回新潟医学会)"}, {"subitem_title": "2) アセチルコリンレセプター抗体と重症筋無力症(シンポジウム レセプターとその臨床, 第443回新潟医学会)", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["456", "1205"], "permalink_uri": "http://hdl.handle.net/10191/41433", "pubdate": {"attribute_name": "公開日", "attribute_value": "2016-04-12"}, "publish_date": "2016-04-12", "publish_status": "0", "recid": "22763", "relation": {}, "relation_version_is_last": true, "title": ["2) アセチルコリンレセプター抗体と重症筋無力症(シンポジウム レセプターとその臨床, 第443回新潟医学会)"], "weko_shared_id": null}
2) アセチルコリンレセプター抗体と重症筋無力症(シンポジウム レセプターとその臨床, 第443回新潟医学会)
http://hdl.handle.net/10191/41433
http://hdl.handle.net/10191/41433f1bc6ed9-bda4-4e95-b4c4-8ede56f42604
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
|
Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2016-04-12 | |||||
タイトル | ||||||
タイトル | 2) アセチルコリンレセプター抗体と重症筋無力症(シンポジウム レセプターとその臨床, 第443回新潟医学会) | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | 2) アセチルコリンレセプター抗体と重症筋無力症(シンポジウム レセプターとその臨床, 第443回新潟医学会) | |||||
言語 | ||||||
言語 | jpn | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Myasthenia gravis | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | anti-acetylcholine receptor antibody | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | acetylcholine receptor | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | peptide map | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 重症筋無力症 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 抗アセチルコリンレセプター抗体 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | アセチルコリンレセプター | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | ペプチドマップ | |||||
資源タイプ | ||||||
資源 | http://purl.org/coar/resource_type/c_6501 | |||||
タイプ | departmental bulletin paper | |||||
その他のタイトル | ||||||
その他のタイトル | Anti-Acetylcholine Receptor Antibody and Myasthenia Gravis(Receptor Diseases) | |||||
著者 |
永井, 博子
× 永井, 博子 |
|||||
著者別名 | ||||||
識別子 | 137918 | |||||
識別子Scheme | WEKO | |||||
姓名 | Nagai, Hiroko | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Anti-acetylcholine receptor (AChR) antibody is highly disease-specific to myasthenia gravis (MG) comparing to other autoimmune disease, and it is rare to detect other autoimmune antibody. Therefore, immune tolerance system of MG seems to be somewhat different from other autoimmune diseases. However, there is a variation in anti-AChR antibody and anti-AChR antibody is not always correlate with clinical severity. AChR is composed of five subunits, two of α and each one of β, γ and δ and has transmembrane stracture. Fifty percent of antibody to native AChR bind to and more than a half of antibody of patient with MG bind to one region, which is called main immunogenic region (MIR) and is located on α subunit. Peptide mapping of each subunit has high homology. Localization of MIR is not established yet. Farther study of MIR, study of AChR using monoclonal antibody to peptid and establishment of antigenic region on AChR are needed. | |||||
書誌情報 |
新潟医学会雑誌 en : 新潟医学会雑誌 巻 103, 号 10, p. 798-800, 発行日 1989-10 |
|||||
出版者 | ||||||
出版者 | 新潟医学会 | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 00290440 | |||||
書誌レコードID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AN00182415 | |||||
著者版フラグ | ||||||
値 | publisher |